Progression of Renal Damage in Glycogen Storage Disease Type I Is Associated to Hyperlipidemia: A Multicenter Prospective Italian Study

被引：15

作者：

Melis, Daniela ^{[1
]}

Cozzolino, Mariarosaria ^{[2
]}

Minopoli, Giorgia ^{[2
]}

Balivo, Francesca ^{[2
]}

Parini, Rossella ^{[3
]}

Rigoldi, Miriam ^{[3
]}

Paci, Sabrina ^{[4
]}

Dionisi-Vici, Carlo ^{[5
]}

Burlina, Alberto ^{[6
]}

Andria, Generoso ^{[2
]}

Parenti, Giancarlo ^{[2
]}

机构：

[1] Univ Naples Federico II, Azienda Osped, Welf Dept Pediat, I-80100 Naples, Italy

[2] Univ Naples Federico II, Sez Pediat, Dept Med Sci, I-80100 Naples, Italy

[3] Osped San Gerardo, Dept Pediat, Monza, Italy

[4] Osped San Paolo, Dept Pediat, Milan, Italy

[5] Bambino Gesu Pediat Hosp, Div Med Pathol, Rome, Italy

[6] Univ Padua, Div Med Pathol, Padua, Italy

来源：

JOURNAL OF PEDIATRICS | 2015年 / 166卷 / 04期

关键词：

NEPHROPATHY; EXPRESSION;

D O I：

10.1016/j.jpeds.2014.12.015

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Angiotensin converting enzyme (ACE)- inhibitors decrease glomerular hyperfiltration but not microalbuminuria and proteinuria in glycogen storage disease type I. In the current study, we demonstrated that severe hyperlipidemia is associated with ACE-inhibitor ineffectiveness. We underline the importance of adequate metabolic control in glycogen storage disease type I. A combination therapy with ACE-inhibitors and lipid lowering drugs might be considered.

引用

页码：1079 / 1082

页数：4

共 29 条

[1] Renal involvement in glycogen storage disease type 1: Practical issues
Ben Chehida, Amel
Bensmail, Takoua
Ben Rehouma, Faten
Ben Abdelaziz, Rim
Azzouz, Hatem
Boudabbous, Hela
Abdelmoula, Mohamed Slim
Abdelhak, Sonia
Kaabachi, Naziha
Ben Turkia, Hadhami
Tebib, Neji
NEPHROLOGIE & THERAPEUTIQUE, 2015, 11 (04): : 240 - 245
[2] Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges
Schumann, Anke
Garbade, Sven F.
Beblo, Skadi
Gautschi, Matthias
Haas, Dorothea
Hochuli, Michel
Hoffmann, Georg
May, Petra
Merkel, Martin
Scholl-Buergi, Sabine
Thimm, Eva
Weinhold, Natalie
Williams, Monika
Wortmann, Saskia
Gruenert, Sarah C.
MOLECULAR GENETICS AND METABOLISM, 2025, 144 (03)
[3] Biomarker panels associated with progression of renal disease in type 1 diabetes
Colombo, Marco
Valo, Erkka
McGurnaghan, Stuart J.
Sandholm, Niina
Blackbourn, Luke A. K.
Dalton, R. Neil
Dunger, David
Groop, Per-Henrik
McKeigue, Paul M.
Forsblom, Carol
Colhoun, Helen M.
DIABETOLOGIA, 2019, 62 (09) : 1616 - 1627
[4] Biomarker panels associated with progression of renal disease in type 1 diabetes
Marco Colombo
Erkka Valo
Stuart J. McGurnaghan
Niina Sandholm
Luke A. K. Blackbourn
R. Neil Dalton
David Dunger
Per-Henrik Groop
Paul M. McKeigue
Carol Forsblom
Helen M. Colhoun
Diabetologia, 2019, 62 : 1616 - 1627
[5] Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry
Kaiser, Nathalie
Gautschi, Matthias
Bosanska, Lenka
Meienberg, Fabian
Baumgartner, Matthias R.
Spinas, Giatgen A.
Hochuli, Michel
MOLECULAR GENETICS AND METABOLISM, 2019, 126 (04) : 355 - 361
[6] Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
Rutten, Martijn G. S.
Lei, Yu
Hoogerland, Joanne H. H.
Bloks, Vincent W. W.
Yang, Hong
Bos, Trijnie
Krishnamurthy, Kishore A. A.
Bleeker, Aycha
Koster, Mirjam H. H.
Thomas, Rachel E. E.
Wolters, Justina C. C.
van den Bos, Hilda
Mithieux, Gilles
Rajas, Fabienne
Mardinoglu, Adil
Spierings, Diana C. J.
de Bruin, Alain
van de Sluis, Bart
Oosterveer, Maaike H. H.
CANCER & METABOLISM, 2023, 11 (01)
[7] Adeno-Associated Virus-Mediated Correction of a Canine Model of Glycogen Storage Disease Type Ia
Weinstein, David A.
Correia, Catherine E.
Conlon, Thomas
Specht, Andrew
Verstegen, John
Onclin-Verstegen, Karine
Campbell-Thompson, Martha
Dhaliwal, Gurmeet
Mirian, Layla
Cossette, Holly
Falk, Darin J.
Germain, Sean
Clement, Nathalie
Porvasnik, Stacy
Fiske, Laurie
Struck, Maggie
Ramirez, Harvey E.
Jordan, Juan
Andrutis, Karl
Chou, Janice Y.
Byrne, Barry J.
Mah, Cathryn S.
HUMAN GENE THERAPY, 2010, 21 (07) : 903 - 910
[8] Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
Saeed, Ali
Hoogerland, Joanne A.
Wessel, Hanna
Heegsma, Janette
Derks, Terry G. J.
van der Veer, Eveline
Mithieux, Gilles
Rajas, Fabienne
Oosterveer, Maaike H.
Faber, Klaas Nico
HUMAN MOLECULAR GENETICS, 2020, 29 (02) : 264 - 273
[9] The effect of linagliptin on renal progression in type-2 diabetes mellitus patients with chronic kidney disease: A prospective randomized controlled study
Yagoglu, Ali Ihsan
Dizdar, Oguzhan Sitki
Erdem, Selahattin
Akcakaya, Berkan
Gunal, Ali Ihsan
NEFROLOGIA, 2020, 40 (06): : 664 - 671
[10] Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study
Satirapoj, Bancha
Aramsaowapak, Kasemsan
Tangwonglert, Theerasak
Supasyndh, Ouppatham
JOURNAL OF DIABETES RESEARCH, 2016, 2016

← 1 2 3 →